Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection

Molecular Microbiology

Volumn 56, Issue 3, 2005, Pages 681-695

  Datta, Vivekanand ^a   Myskowski, Sandra M ^a   Kwinn, Laura A ^a   Chiem, Daniel N ^a   Varki, Nissi ^b   Kansal, Rita G ^c   Kotb, Malak ^c   Nizet, Victor ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; M PROTEIN; STREPTOLYSIN S;

ARTICLE; BACTERIAL INFECTION; BACTERIAL MUTATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOTOXICITY; GENE; GENE DELETION; NONHUMAN; OPERON; PATHOGENESIS; PHAGOCYTE; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; SAGA GENE; SAGB GENE; SAGC GENE; SAGD GENE; SAGE GENE; SAGF GENE; SAGG GENE; SITE DIRECTED MUTAGENESIS; SKIN NECROSIS; SKIN ULCER; STREPTOCOCCUS GROUP A; SYSTEMIC CIRCULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARRIER PROTEINS; GENETIC COMPLEMENTATION TEST; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; OPERON; PHAGOCYTOSIS; SKIN DISEASES, BACTERIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; STREPTOLYSINS; VIRULENCE;

EID: 17644385827     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2005.04583.x     Document Type: Article

References (73)

1. Alouf, J.E., and Loridan, C. (1988) Production, purification, and assay of streptolysin S. Methods Enzymol 165: 59-64.
2. Ashbaugh, C.D., Warren, H.B., Carey, V.J., and Wessels, M.R. (1998) Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest 102: 550-560.
3. Bernheimer, A.W. (1966) Disruption of wall-less bacteria by streptococcal and staphylococcal toxins. J Bacteriol 91: 1677-1680.
4. Bernheimer, A.W. (1967) Physical behavior of streptolysin S. J Bacteriol 93: 2024-2025.
5. Betschel, S.D., Borgia, S.M., Barg, N.L., Low, D.E., and De Azavedo, J.C. (1998) Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun 66: 1671-1679.
6. Bisno, A.L., Brito, M.O., and Collins, C.M. (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3: 191-200.
7. Biswas, I., Germon, P., McDade, K., and Scott, J.R. (2001) Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. Infect Immun 69: 7029-7038.
8. Borgia, S.M., Betschel, S., Low, D.E., and de Azavedo, J.C. (1997) Cloning of a chromosomal region responsible for streptolysin S production in Streptococcus pyogenes. Adv Exp Med Biol 418: 733-736.
9. Boukamp, P., Petrussevska, R.T., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, N.E. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771.
10. Carr, A., Sledjeski, D.D., Podbielski, A., Boyle, M.D., and Kreikemeyer, B. (2001) Similarities between complement-mediated and streptolysin S-mediated hemolysis. J Biol Chem 276: 41790-41796.
11. Chaffin, D.O., and Rubens, C.E. (1998) Blue/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression. Gene 219: 91-99.
12. Chaffin, D.O., Yim, H.H., and Rubens, C.E. (1998) New vectors for blue-white screening and in vitro expression (IVET) in Gram-positive bacteria. In American Society for Microbiology Conference on Streptococcal Genetics, Vichy, France.
13. Chatellier, S., Ihendyane, N., Kansal, R.G., Khambaty, F., Basma, H., Norrby-Teglund, A., et al. (2000) Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 68: 3523-3534.
14. Cleary, P.P., LaPenta, D., Vessela, R., Lam, H., and Cue, D. (1998) A globally disseminated M1 subclone of group A streptococci differs from other subclones by 70 kilobases of prophage DNA and capacity for high-frequency intracellular invasion. Infect Immun 66: 5592-5597.
15. Cockerill, F.R., 3rd, MacDonald, K.L., Thompson, R.L., Roberson, F., Kohner, P.C., Besser-Wiek, J., et al. (1997) An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 277: 38-43.
16. Cunningham, M.W. (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470-511.
17. Dale, J.B., Chiang, E.Y., Hasty, D.L., and Courtney, H.S. (2002) Antibodies against a synthetic peptide of SagA neutralize the cytolytic activity of streptolysin S from group A streptococci. Infect Immun 70: 2166-2170.
18. Diep, D.B., Havarstein, L.S., and Nes, I.F. (1996) Characterization of the locus responsible for the bacteriocin production in Lactobacillus plantarum C11. J Bacteriol 178: 4472-4483.
19. Doran, K.S., Chang, J.C., Benoit, V.M., Eckmann, L., and Nizet, V. (2002) Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. J Infect Dis 185: 196-203.
20. Dorschner, R.A., Pestonjamasp, V.K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., et al. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117: 91-97.
21. Eberhard, T.H., Sledjeski, D.D., and Boyle, M.D. (2001) Mouse skin passage of a Streptococcus pyogenes Tn917 mutant of sagA/pel restores virulence, beta-hemolysis and sagA/pel expression without altering the position or sequence of the transposon. BMC Microbiol 1: 33.
22. Efstratiou, A. (2000) Group A streptococci in the 1990s. J Antimicrob Chemother 45 (Suppl.): 3-12.
23. Engleberg, N.C., Heath, A., Vardaman, K., and DiRita, V.J. (2004) Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes. Infect Immun 72: 623-628.
24. Federle, M.J., McIver, K.S., and Scott, J.R. (1999) A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol 181: 3649-3657.
25. Ferretti, J.J., McShan, W.M., Ajdic, D., Savic, D.J., Savic, G., Lyon, K., et al. (2001) Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 98: 4658-4663.
26. Fontaine, M.C., Lee, J.J., and Kehoe, M.A. (2003) Combined contributions of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo. Infect Immun 71: 3857-3865.
27. Framson, P.E., Nittayajarn, A., Merry, J., Youngman, P., and Rubens, C.E. (1997) New genetic techniques for group B streptococci: high-efficiency transformation, maintenance of temperature-sensitive pWV01 plasmids, and mutagenesis with Tn917. Appl Environ Microbiol 63: 3539-3547.
28. Fuller, J.D., Camus, A., Duncan, C.L., Nizet, V., Bast, D.J., Thune, R.L., et al. (2002) Discovery of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease. Infect Immu 70: 5730-5739.
29. Gibson, R.L., Nizet, V., and Rubens, C.E. (1999) Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr Res 45: 626-634.
30. Ginsburg, I. (1972) Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae. J Infect Dis 126: 294-340.
31. Ginsburg, I. (1999) Is streptolysin S of group A streptococci a virulence factor? APMIS 107: 1051-1059.
32. Grant, S.G., Jessee, J., Bloom, F.R., and Hanahan, D. (1990) Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. Proc Natl Acad Sci USA 87: 4645-4649.
33. Heath, A., DiRita, V.J., Barg, N.L., and Engleberg, N.C. (1999) A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun 67: 5298-5305.
34. Hoffmann, A., Schneider, T., Pag, U., and Sahl, H.G. (2004) Localization and functional analysis of Pepl, the immunity peptide of Pep5-producing Staphylococcus epidermidis strain 5. Appl Environ Microbiol 70: 3263-3271.
35. Holo, H., and Nes, I.F. (1989) High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stablized media. Appl Environ Microbiol 55: 3119-3123.
36. Hryniewicz, W., and Pryjma, J. (1977) Effect of streptolysin S on human and mouse T and B lymphocytes. Infect Immun 16: 730-733.
37. Humar, D., Datta, V., Bast, D.J., Beall, B., De Azavedo, J.C., and Nizet, V. (2002) Streptolysin S and necrotising infections produced by group G streptococcus. Lancet 359: 124-129.
38. Jack, R.W., Carne, A., Metzger, J., Stefanovic, S., Sahl, H.G., Jung, G., and Tagg, J. (1994) Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22. Eur J Biochem 220: 455-462.
39. Jack, R.W., Tagg, J.R., and Ray, B. (1995) Bacteriocins of gram-positive bacteria. Microbiol Rev 59: 171-200.
40. Jeng, A., Sakota, V., Li, Z., Datta, V., Beall, B., and Nizet, V. (2003) Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J Bacteriol 185: 1208-1217.
41. Kansal, R.G., McGeer, A., Low, D.E., Norrby-Teglund, A., and Kotb, M. (2000) Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun 68: 6362-6369.
42. Keiser, H., Weissmann, G., and Bernheimer, A.W. (1964) Studies on lysosomes. IV. Solubilization of enzymes during mitochondrial swelling and disruptions of lysosomes by streptolysins and other hemolytic agents. J Cell Biol 22: 101.
43. Kihlberg, B.M., Cooney, J., Caparon, M.G., Olsen, A., and Bjorck, L. (1995) Biological properties of a Streptococcus pyogenes mutant generated by Tn976 insertion in mga. Microb Pathog 19: 299-315.
44. Kobayashi, S.D., Braughton, K.R., Whitney, A.B., Voyich, J.M., Schwan, T.G., Musser, J.M., and DeLeo, F.R. (2003) Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci USA 100: 10948-10953.
45. Koyama, J. (1963) Biochemical studies on streptolysin S II. Properties of a polypeptide component and its role in the toxin activity. J Biochem 54: 146-151.
46. van Kraaij, C., Breukink, E., Noordermeer, M.A., Demel, R.A., Siezen, R.J., Kuipers, O.P., and de Kruijff, B. (1998) Pore formation by nisin involves translocation of its C-terminal part across the membrane. Biochemistry 37: 16033-16040.
47. Kuipers, O.P., de Ruyter, P.G.G.A., Kleerebezem, M., and de Vos, W.M. (1998) Quorum sensing-controlled gene expression in lactic acid bacteria. J Biotechnol 64: 15-21.
48. LaPenta, D., Rubens, C., Chi, E., and Cleary, P.P. (1994) Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci USA 91: 12115-12119.
49. LeBlanc, D.J., Lee, L.N., and Abu-Al-Jaibat, A. (1992) Molecular, genetic, and functional analysis of the basic replicon of pVA380-1, a plasmid of oral streptococcal origin. Plasmid 28: 130-145.
50. Li, Z., Sledjeski, D.D., Kreikemeyer, B., Podbielski, A., and Boyle, M.D. (1999) Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol 181: 6019-6027.
51. Madison, L.L., Vivas, E.I., Li, Y.M., Walsh, C.T., and Kolter, R. (1997) The leader peptide is essential for the posttranslational modification of the DNA-gyrase inhibitor microcin B17. Mol Microbiol 23: 161-168.
52. Maguin, E., Duwat, P., Hege, T., Ehrlich, D., and Gruss, A. (1992) New thermosensitive plasmid for gram-positive bacteria. J Bacteriol 174: 5633-5638.
53. de Malmanche, S.A., and Martin, D.R. (1994) Protective immunity to the group A Streptococcus may be only strain specific. Med Microbiol Immunol (Berl) 183: 299-306.
54. Mangold, M., Siller, M., Roppenser, B., Vlaminckx, B.J., Penfound, T.A., Klein, R., et al. (2004) Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Mol Microbiol 53: 1515-1527.
55. Murono, K., Fujita, K., Saijo, M., Hirano, Y., Zhang, J., and Murai, T. (1999) Emergence and spread of a new clone of M type 1 group A Streptococcus coincident with the increase in invasive diseases in Japan. Pediatr Infect Dis J 18: 254-257.
56. Nakai, K., and Horton, P. (1999) PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem Sci 24: 34-36.
57. Nizet, V. (2002) Streptococcal beta-hemolysins: genetics and role in disease pathogenesis. Trends Microbiol 10: 575-580.
58. Nizet, V., Gibson, R.L., Chi, E.Y., Framson, P.E., Hulse, M., and Rubens, C.E. (1996) Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 64: 3818-3826.
59. Nizet, V., Beall, B., Bast, D.J., Datta, V., Kilburn, L., Low, D.E., and De Azavedo, J.C. (2000) Genetic locus for streptolysin S production by group A streptococcus. Infect Immun 68: 4245-4254.
60. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R.A., et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
61. Ofek, I., Zafriri, D., Goldhar, J., and Eisenstein, B.I. (1990) Inability of toxin inhibitors to neutralize enhanced toxicity caused by bacteria adherent to tissue culture cells. Infect Immun 58: 3737-3742.
62. Pritzlaff, C.A., Chang, J.C., Kuo, S.P., Tamura, G.S., Rubens, C.E., and Nizet, V. (2001) Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Mol Microbiol 39: 236-247.
63. Rose, R.E. (1988) The nucleotide sequence of pACYC184. Nucleic Acids Res 16: 355.
64. Ross, K.F., Ronson, C.W., and Tagg, J.R. (1993) Isolation and characterization of the lantibiotic salivaricin A and its structural gene sa/A from Streptococcus salivarius 20P3. Appl Environ Microbiol 59: 2014-2021.
65. Sahl, H.G., and Bierbaum, G. (1998) Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu Rev Microbiol 52: 41-79.
66. Sharkawy, A., Low, D.E., Saginur, R., Gregson, D., Schwartz, B., Jessamine, P., et al. (2002) Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 34: 454-460.
67. Sierig, G., Cywes, C., Wessels, M.R., and Ashbaugh, C.D. (2003) Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci. Infect Immun 71: 446-455.
68. Simon, D., and Ferretti, J.J. (1991) Electrotransformation of Streptococcus pyogenes with plasmid and linear DNA. FEMS Microbiol Lett 66: 219-224.
69. Stevens, D.L. (1999) The flesh-eating bacterium: what's next? J Infect Dis 179 (Suppl. 2): S366-S374.
70. Taketo, Y., and Taketo, A. (1966) Cytolytic effect of streptolysin S complex on Ehrlich ascites tumor cells. J Biochem (Tokyo) 60: 357-362.
71. Wertman, K.F., Wyman, A.R., and Botstein, D. (1986) Host/vector interactions which affect the viability of recombinant phage lambda clones. Gene 49: 253-262.
72. Wescombe, P.A., and Tagg, J.R. (2003) Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes. Appl Environ Microbiol 69: 2737-2747.
73. Woodcock, D.M., Crowther, P.J., Doherty, J., Jefferson, S., DeCruz, E., Noyer-Weidner, M., et al. (1989) Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res 17: 3469-3478.